Does SIPULEUCEL-T Cause Poor venous access? 20 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Poor venous access have been filed in association with SIPULEUCEL-T (PROVENGE). This represents 0.4% of all adverse event reports for SIPULEUCEL-T.
20
Reports of Poor venous access with SIPULEUCEL-T
0.4%
of all SIPULEUCEL-T reports
0
Deaths
1
Hospitalizations
How Dangerous Is Poor venous access From SIPULEUCEL-T?
Of the 20 reports, 1 (5.0%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPULEUCEL-T. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does SIPULEUCEL-T Cause?
Chills (447)
Infusion related reaction (414)
Pyrexia (255)
Fatigue (249)
Malaise (233)
Nausea (205)
Disease progression (185)
Ill-defined disorder (185)
Culture positive (174)
Asthenia (164)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which SIPULEUCEL-T Alternatives Have Lower Poor venous access Risk?
SIPULEUCEL-T vs SIROLIMUS
SIPULEUCEL-T vs SIRUKUMAB
SIPULEUCEL-T vs SITAGLIPTIN
SIPULEUCEL-T vs SOAP
SIPULEUCEL-T vs SODIUM